Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1995-06-07
1999-12-14
Stanton, Brian R.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536 245, 4353201, C07H 2104, C12N 1500
Patent
active
060019905
ABSTRACT:
The invention features antisense oligonucleotides and methods of using these antisense oligonucleotides for inhibiting HCV RNA translation.
REFERENCES:
patent: 3625214 (1971-12-01), Higuchi
patent: 4689320 (1987-08-01), Kaji
patent: 4789734 (1988-12-01), Pierschbacher
patent: 4925673 (1990-05-01), Steiner et al.
patent: 5399345 (1995-03-01), Schumacher et al.
patent: 5559028 (1996-09-01), Humphreys
Westermann et al., Biomed. Biochem. Acta, 48(1):85-93, 1989.
Bennet, Science, 271:434, 1996.
Weiss, Science News, 139:108-109, 1991.
Stull et al., Pharmaceutical Research, 12(4):465-483, 1995.
Wu-Pong, Pharmaceutical Technology, 18:102-114, 1994.
Gura, Science, 270;575-577, 1995.
Miller et al., Parasitology Today, 10(3):92-97, 1994.
Rojanasakul, Advanced Drug Delivery Reviews, 18:115-131, 1996.
Brown et al., Secondary Structure of the 5' Nontranslated Regions of Hepatitis C Virus and Pestivirus Genomic RNAs, Nucleic Acids Res., 20:5041-45.
Bukh et al., Sequence analysis of the 5' noncoding region of hepatitis C virus, Proc. Natl. Acad. Sci. USA 89:4942-4946, 1992.
Engelhardt et al., Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver, Proc. Natl. Acad. Sci. USA 91:6196-6200, 1994.
Ghosh et al., Oligodeoxynucleotides as antisense inhibitors of gene expression, Prog. Nuc. Acids Res., 42:79-127, 1992.
Gossen et al., Tight control of gene expression in mammalian cells by tetracycline-responsive promoters, Proc. Natl. Acad. Sci. USA 89:5547-5551, 1992.
Kern, Preclinical Evaluation of Antiviral Agents: In Vitro and Animal Model Testing, Antiviral Agents and Vital Diseases of Man, Raven Press, Ltd., NY, Ch. 3, pp. 87-95, 1990.
Matsukura et al., Phosphorothioate analogs of oligodeoxynucleotides: Inhibitors of replication and cytopathic effects of human immunodeficiency virus, Proc. Natl. Acad. Sci. USA 84:7706-7710, 1987.
Milligan et al., Current concepts in antisense drug design, J. Med. Chem. 36(14):1923-1937, 1993.
Uhlmann et al., Antisense Oligonucleotides: A new therapeutic principle, Chemical Reviews 90(4):543-584, 1990.
Von Ruden et al., Inhibition of Human T-Cell Leukemia Virus Type I Replication in Primary Human T Cells that Express Antisense RNA, J. Virology, 63:677-82, 1989.
Wagner, Richard W., Gene inhibition using antisense of oligodeoxynucleotides, Nature 372:333-335, 1994.
Wakita et al., Specific inhibition of hepatitis C virus expression by antisense oligodeoxynucleotides, J. Biol. Chem. 269(19):14205-14210, 1994.
Wolff et al., Direct gene transfer into mouse muscle in vivo, Science 247:1465-1468, 1990.
Benoist et al., In Vivo Sequence Requirements of the SV40 Early Promoter Region, Nature 290:304-10, 1981.
Blum et al., Inhibition of Hepatitis B Virus by Antisense Oligodeoxynucleotides, Lancet 337:1230, 1991.
Brown et al., Secondary Structure of the 5'Nontranslated Regions of Hepatitis C Virus and Pestivirus Genomic RNAs, Nucleic Acids Research 20:5041-5045, 1992.
Choo et al., Genetic Organization and Diversity of the Hepatitis C Virus, Proc. Natl. Acad. Sci. USA 88:2451-2455, 1991.
Crooke, Therapeutic Applications of Oligonucleotides, Annu. Rev. Pharmacol. Toxicol. 32:329-76, 1992.
DeBernardi et al., Inhibition of cAMP Accumulation by Intracellular Calcium Mobilization in C6-2B Cells Stably Transfected with Substance K Receptor cDNA, Proc. Natl. Acad. Sci. USA 88:9257-9261, 1991.
Dolnick, Commentary: Antisense Agents in Pharmacology, Biochemical Pharmacology 40:671-675, 1990.
Goodarzi et al., Antisense Oligodeoxyribonucleotides Inhibit the Expression of the Gene for Hepatitis B Virus Surface Antigen, J. General Virology 71:3021-3025, 1990.
Graham et al., Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5, J. Gen. Virology 36:59-72, 1977.
Hamer and Walling, Regulation In Vivo of a Cloned Mammalian Gene: Cadmium Induces the Transcription of a Mouse Metallothionein Gene in SV40 Vectors, J. Molecular and Applied Genetics 1:273-288, 1982.
Han et al., Characterization of the Terminal Regions of Hepatitis C Viral RNA: Identification of Conserved Sequences . . . Region and poly(A) Tails at the 3' End, Proc. Natl. Acad. Sci. USA 88:1711-1715, 1991.
Hijikata et al., Gene Mapping of the Putative Structural Region of the Hepatitis C Virus Genome by in Vitro Processing Analysis, Proc. Natl. Acad. Sci. USA 88:5547-5551, 1991.
Hoofnagle et al., Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha Interferon, N. Eng. J. Med. 315:1575-1578, 1986.
Inchauspe et al., Genomic Structure of the Human Prototype Strain H of Hepatitis C Virus: Comparison with American and Japanese Isolates, Proc. Natl. Acad. Sci. USA 88:10292-10296, 1991.
Kabanov et al., A New Class of Antivirals: Antisense Oligonucleotides Combined with a Hydrophobic . . . Reproduction and Synthesis of Virus-Specific Proteins in MDCK Cells, Febs Letters, 259:327-330, 1990.
Kiyosawa et al., Interrelationship of Blood Transfusion, Non-A, Non-B Hepatitis and Hepatocellular Carcinoma: Analysis by Detection of Antibody to Hepatitis C Virus, Hepatology 12:671-675, 1990.
Kotin et al., Site-specific Integration by Adeno-associated Virus, Proc. Natl. Acad. Sci. USA 87:2211-2215, 1990.
Kuo et al., An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis, Science 244:362-364, 1989.
Le Doan et al., Antisense Oligonucleotides as Potential Antiviral and Anticancer Agents, Bull. Cancer 76:849-852, 1989.
Lemaitre et al., Specific Antiviral Activity of a Poly(L-lysine)-conjugated Oligodeoxyribonucleotide . . . Vesicular Stomatitis Virus N Protein mRNA Initiation Site, Proc. Natl. Acad. Sci. USA 84:648-652, 1987.
Lisziewicz et al., Specific Inhibition of Human Immunodeficiency Virus Type 1 Replication by Antisense Oligonucleotides: An In Vitro Model for Treatment, Proc. Natl. Acad. Sci. USA 89:11209-11213, 1992.
McKnight, Functional Relationships Between Transcriptional Control Signals of the Thymidine Kinase Gene of Herpes Simplex Virus, Cell 31:355-365, 1982.
Morsy et al., Efficient Adenoviral Gene Transduction in Human and Mouse Hepatocytes In Vitro and in Mouse Liver In Vivo, J. Cell. Biochem., Suppl. 17E:SZ109, 1993.
Offensperger et al., In Vivo Inhibition of Duck Hepatitis B Virus Replication and Gene Expression by Phosphorothioate Modified Antisense Oligodeoxynucleotides, Embo J. 12:1257-1262, 1993.
Okamoto et al., Nucleotide Sequence of the Genomic RNA of Hepatitis C Virus Isolated from a Human Carrier: Comparison with Reported Isolates for Conserved and Divergent Regions, J. Gen. Virol. 72:2697-2704, 1991.
Okamoto et al., Full-Length Sequence of a Hepatitis C Virus Genome Having Poor Homology to Reported Isolates: Comparative Study of Four Distinct Genotypes, Virology 188:331-341, 1992.
Rosenberg et al., Gene Transfer into Humans--Immunmotherapy of Patients with Advanced Melanoma, using Lung Tumor-Infiltrating Lymphocytes Modified by Retroviral Gene Transduction, N. Eng. J. Med. 323:570-578, 1990.
Smith et al., Antiviral Effect of an Oligo(nucleoside methylphosphonate) Complementary to the Splice . . . Simplex Virus Type 1 Immediate Early pre-mRNAs 4 and 5, Proc. Natl. Acad. Sci. USA 83:2787-2791, 1986.
Spiess, The Asialoglycoprotein Receptor: A Model for Endocytic Transport Receptors, Biochemistry 29:10009-10018, 1990.
Stein and Cheng, Antisense Oligonucleotides as Therapeutic Agents--Is the Bullet Really Magical, Science 261:1004-1012, 1993.
Tsukiyama-Kohara et al., Internal Ribosome Entry Site within Hepatitis C Virus RNA, J. Virology 66:1476-1483, 1992.
Wang et al., Translation of Human Hepatitis C Virus RNA in Cultured Cells is Mediated by an Internal Ribosome-Binding Mechanism, J. Virology 67:3338-3344, 1993.
Wu and Wu, Specific Inhibition of Hepatitis B Viral Gene Expression In Vitro by Targeted Antisense Oligonucleotides, J. Biol. Chem. 267:12436-12439, 1992.
Yoshioka et al., Detection of Hepatitis C Virus by Polymerase Chain Reaction and Response to Interferon-.alpha. Therapy: Relationship to Genotypes of Hepatitis C Virus, Hepatology 16:293-299, 1992.
Zamecnik et al.
Moradpour Darius
Wakita Takaja
Wands Jack R.
Clark Deborah J. R.
Stanton Brian R.
The General Hospital Corporation
LandOfFree
Antisense inhibition of hepatitis C virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense inhibition of hepatitis C virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense inhibition of hepatitis C virus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-864764